UMIN000050478
A prospEctive observatioNal study evaluating profiling of T cell binding to anti-PD-1 antibody using peripHeral blood as signAture for tumor respoNse during ramuCirumab and docEtaxel afteR anti-PD-1 antibody
Graduate School of Medicine, Osaka University·University Hospital Medical Information NetworkRecruiting
Study focus
- Disease/Condition
- Non-small cell lung cancer
- Study type
- Observational
Sponsor & location
- Primary sponsor
- Graduate School of Medicine, Osaka University
- Location
- Japan
Timeline & enrollment
- Phase
- N/A
- Start date
- Mar 03, 2023
- End date
- N/A
ICD-10 classifications
Secondary malignant neoplasm of lungMalignant neoplasm: Lower lobe, bronchus or lungMalignant neoplasm: Middle lobe, bronchus or lungMalignant neoplasm: Bronchus or lung, unspecifiedMalignant neoplasm of bronchus and lung
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000050478
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for UMIN000050478 through Pure Global AI's free database. This phase not specified trial is sponsored by Graduate School of Medicine, Osaka University and is currently Recruiting. The study focuses on Non-small cell lung cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.